Cite

Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet 2016; 387: 1094-108. doi: 10.1016/S0140-6736(15)00130-0MoricePLearyACreutzbergCAbu-RustumNDaraiEEndometrial cancerLancet2016387109410810.1016/S0140-6736(15)00130-0Open DOISearch in Google Scholar

Bray F, Dos Santos Silva I, Moller H, Weiderpass E. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention. Cancer Epidemiol Biomarkers Prev 2005; 14: 1132-42. doi: 10.1158/1055-9965.EPI-04-0871BrayFDosSantos Silva IMollerHWeiderpassE.Endometrial cancer incidence trends in Europe: underlying determinants and prospects for preventionCancer Epidemiol Biomarkers Prev20051411324210.1158/1055-9965.EPI-04-087115894663Open DOISearch in Google Scholar

Siegel R, Miller KD, Jemal A. Cancer statistics 2015. CA Cander J Clin 2015; 65: 5-29. doi: 10.3322/caac.21254SiegelRMillerKDJemalACancer statistics 2015CA Cander J Clin20156552910.3322/caac.2125425559415Open DOISearch in Google Scholar

Galceran J, Ameijide A, Carulla M, Mateos A, Quirós JR, Rojas D, et al. REDECAN Working Group. Cancer incidence in Spain, 2015. Clin Transl Oncol 2017; 19: 799-825. doi: 10.1007/s12094-016-1607-9GalceranJAmeijideACarullaMMateosAQuirósJRRojasDet alREDECAN Working GroupCancer incidence in Spain, 2015. Clin Transl Oncol20171979982510.1007/s12094-016-1607-928093701Open DOISearch in Google Scholar

Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 2009; 105: 109. doi: 10.1016/j.ijgo.2009.02.010CreasmanWRevised FIGO staging for carcinoma of the endometriumInt J Gynaecol Obstet200910510910.1016/j.ijgo.2009.02.01019345353Open DOISearch in Google Scholar

Beddy P, O’Neill AC, Yamamoto AK, Addley HC, Reinhold C, Sala E. FIGO staging system for endometrial cancer: added benefits of MR imaging. Radiographics 2012; 32: 241-54. doi: 10.1148/rg.321115045BeddyPO’NeillACYamamotoAKAddleyHCReinholdCSalaEFIGO staging system for endometrial cancer: added benefits of MR imagingRadiographics2012322415410.1148/rg.32111504522236905Open DOISearch in Google Scholar

Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008; 109: 11-8. doi: 10.1016/j.ygyno.2008.01.023MarianiADowdySCClibyWAGostoutBSJonesMBWilsonTOet alProspective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical stagingGynecol Oncol200810911810.1016/j.ygyno.2008.01.023366739118304622Open DOISearch in Google Scholar

Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al. ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group. ESMO-ESGO-ESTRO Consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer 2016; 26: 2-30. doi: 10.1097/IGC.0000000000000609.ColomboNCreutzbergCAmantFBosseTGonzález-MartínALedermannJet alESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group. ESMO-ESGO-ESTRO Consensus conference on endometrial cancer: diagnosis, treatment and follow-upInt J Gynecol Cancer20162623010.1097/IGC.0000000000000609467934426645990Open DOISearch in Google Scholar

Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000; 182: 1506-19. doi: 10.1067/mob.2000.107335MarianiAWebbMJKeeneyGLHaddockMGCaloriGPodratzKCLow-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?Am J Obstet Gynecol200018215061910.1067/mob.2000.10733510871473Open DOISearch in Google Scholar

Alhilli, MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME et al. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol 2013; 128: 294-9. doi: 10.1016/j.ygyno.2012.10.009AlhilliMM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree MEet alPreoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancerGynecol Oncol2013128294910.1016/j.ygyno.2012.10.00923085458Open DOISearch in Google Scholar

Coronado PJ, Rychlik A, Martínez-Maestre MA, Baquedano L, Fasero M, García-Arreza A, et al. Role of lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair study. J Gynecol Oncol 2018; 29: e1. doi: 10.3802/jgo.2018.29e1CoronadoPJRychlikAMartínez-MaestreMABaquedanoLFaseroMGarcía-ArrezaAet alRole of lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair studyJ Gynecol Oncol201829e110.3802/jgo.2018.29e1Open DOISearch in Google Scholar

Coronado PJ, Fasero M, Baquedano L, Martinez-Maestre MA, Casado A, Vidart JA, et al. Impact of the lymphadenectomy in high-risk histologic types of endometrial cancer: a matched-pair study. Int J Gynecol Cancer 2014; 24: 703-12. doi: 10.1097/IGC.0000000000000120CoronadoPJFaseroMBaquedanoLMartinez-MaestreMACasadoAVidartJAet alImpact of the lymphadenectomy in high-risk histologic types of endometrial cancer: a matched-pair studyInt J Gynecol Cancer2014247031210.1097/IGC.000000000000012024651627Open DOISearch in Google Scholar

TNM atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours In: Writtekind Ch, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH, editors. 5th edition. Berlin, Heidelberg: Springer-Verlag; 2004.TNM atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours In: Writtekind Ch, Greene FL, Hutter RVP, Klimpfinger M, Sobin LH, editors. 5th editionBerlin, HeidelbergSpringer-Verlag;2004Search in Google Scholar

Milam MR, Java J, Walker JL, Metzinger DS, Parker LP, Coleman RL. Gynecologic Oncology Group. Nodal metastasis risk in endometrioid endometrial cancer. Obstet Gynecol 2012; 119: 286-92. doi: 10.1097/AOG.0b013e318240de51MilamMRJavaJWalkerJLMetzingerDSParkerLPColemanRLGynecologic Oncology Group. Nodal metastasis risk in endometrioid endometrial cancerObstet Gynecol20121192869210.1097/AOG.0b013e318240de51326653122270280Open DOISearch in Google Scholar

Todo Y, Sakuragi N, Nishida R, Yamada T, Ebina Y, Yamamoto R, Fujimoto S. Combined use of magnetic resonance imaging, CA 125 assay, histologic type, and histologic grade in the prediction of lymph node metastasis in endometrial carcinoma. Am J Obstet Gynecol 2003; 188: 1265-72. doi: 10.1067/mob.2003.318TodoYSakuragiNNishidaRYamadaTEbinaYYamamotoRFujimotoSCombined use of magnetic resonance imaging, CA 125 assay, histologic type, and histologic grade in the prediction of lymph node metastasis in endometrial carcinomaAm J Obstet Gynecol200318812657210.1067/mob.2003.31812748496Open DOISearch in Google Scholar

Todo Y, Okamoto K, Hayashi M, Minobe S, Nomura E, Hareyama H, et al. A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial carcinoma for tailoring the indication of lymphadenectomy. Gynecol Oncol 2007; 104: 623-8. doi: 10.1016/j.ygyno.2006.10.002TodoYOkamotoKHayashiMMinobeSNomuraEHareyamaHet alA validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial carcinoma for tailoring the indication of lymphadenectomyGynecol Oncol2007104623810.1016/j.ygyno.2006.10.00217097721Open DOISearch in Google Scholar

Oncoguía SEGO (ES). [Guide of practice clinic in cancer gynaecology and senology]. [Spanish]. Madrid: Publicaciones SEGO; 2010.OncoguíaSEGO (ES).[Guide of practice clinic in cancer gynaecology and senology]. [Spanish]MadridPublicaciones SEGO;2010Search in Google Scholar

Todo Y, Watari H, Okamoto K, Hareyama H, Minobe S, Kato H, et al. Tumor volume successively reflects the state of disease progression in endometrial cancer. Gynecol Oncol 2013; 129: 472-7. doi: 10.1016/j.ygyno.2013.02.034TodoYWatariHOkamotoKHareyamaHMinobeSKatoHet alTumor volume successively reflects the state of disease progression in endometrial cancerGynecol Oncol2013129472710.1016/j.ygyno.2013.02.03423474346Open DOISearch in Google Scholar

Todo Y, Choi HJ, Kang S, Kim JW,Nam JH, Watari H, et al. Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperate study. Gynecol Oncol 2013; 131: 294-8. doi: 10.1016/j.ygyno.2013.08.008TodoYChoiHJKangSKimJWNamJHWatariHet alClinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperate studyGynecol Oncol2013131294810.1016/j.ygyno.2013.08.00823954595Open DOISearch in Google Scholar

Chung HH, Lee I, Kim HS, Kim JW, Park NH, Song YS, et al. Prognostic value of preoperative metabolic tumor volume measured by 18F-FDG PET/CT and MRI in patients with endometrial cancer. Gynecol Oncol 2013; 130: 446-51. doi: 10.1016/j.ygyno.2013.06.021ChungHHLeeIKimHSKimJWParkNHSongYSet alPrognostic value of preoperative metabolic tumor volume measured by 18F-FDG PET/CT and MRI in patients with endometrial cancerGynecol Oncol20131304465110.1016/j.ygyno.2013.06.02123791826Open DOISearch in Google Scholar

Guo Y, Wang P, Wang P, Gao W, Li F, Yang X, et al. Myometrial invasion and overall staging of endometrial carcinoma: assessment using fusion of T2-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imaging. Onco Targets Ther 2017; 10: 5937-43. doi: 10.2147/OTT.S145763GuoYWangPWangPGaoWLiFYangXet alMyometrial invasion and overall staging of endometrial carcinoma: assessment using fusion of T2-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imagingOnco Targets Ther20171059374310.2147/OTT.S145763573599229290687Open DOISearch in Google Scholar

Frühauf F, Zikan M, Semeradova I, Dundr P, Nemejcova K, Dusek L, et al. The diagnostic accuracy of ultrasound in assessment of myometrial invasion in endometrial cancer: subjective assessment versus objective techniques. Biomed Res Int 2017; 2017: 1318203. doi: 10.1155/2017/1318203FrühaufFZikanMSemeradovaIDundrPNemejcovaKDusekLet alThe diagnostic accuracy of ultrasound in assessment of myometrial invasion in endometrial cancer: subjective assessment versus objective techniquesBiomed Res Int20172017131820310.1155/2017/1318203554606928812010Open DOISearch in Google Scholar

Ruiz R, Gorostidi M, Jaunarena I, Goiri C, Aguerre J, Lekuona A. Sentinel node biopsy in endometrial cancer with dual cervical and fundal indocyanine green injection. Int J Gynecol Cancer 2018; 28: 139-44. doi: 10.1097/IGC.0000000000001151RuizRGorostidiMJaunarenaIGoiriCAguerreJLekuonaASentinel node biopsy in endometrial cancer with dual cervical and fundal indocyanine green injectionInt J Gynecol Cancer2018281394410.1097/IGC.000000000000115129194192Open DOISearch in Google Scholar

eISSN:
1581-3207
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology, Radiology